| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.7% | 72.6% | ▲ +1.9% |
| Healthcare Services | 15.9% | 18.3% | ▲ +2.4% |
| Retailing | 5.4% | 5.1% | ▼ -0.3% |
| Chemicals & Petrochemicals | 1.2% | 1.2% | ● 0.0% |
| Insurance | 1.1% | 1.1% | ● -0.1% |
| Healthcare Equipment & Supplies | 0.7% | 0.7% | ● +0.0% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Apollo Hospitals Enterprise Limited ₹158.02 Cr |
Healthcare Services | 2.30% |
| 2 | Gland Pharma Limited ₹134.91 Cr |
Pharmaceuticals & Biotechnology | 1.97% |
| 3 | Indraprastha Medical Corporation Limited ₹32.07 Cr |
Healthcare Services | 0.47% |
| 4 | Natco Pharma Limited ₹1.36 Cr |
Pharmaceuticals & Biotechnology | 0.02% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Dr. Reddy's Laboratories Limited ₹667.57 Cr |
Pharmaceuticals & Biotechnology | 8.26% | 9.73% | +1.47% |
| 2 | Biocon Limited ₹365.74 Cr |
Pharmaceuticals & Biotechnology | 4.68% | 5.33% | +0.65% |
| 3 | Pfizer Limited ₹166.32 Cr |
Pharmaceuticals & Biotechnology | 1.86% | 2.42% | +0.56% |
| 4 | Syngene International Limited ₹240.30 Cr |
Healthcare Services | 3.29% | 3.50% | +0.21% |
| 5 | Abbott India Limited ₹174.58 Cr |
Pharmaceuticals & Biotechnology | 2.38% | 2.54% | +0.16% |
| 6 | MedPlus Health Services Limited ₹295.65 Cr |
Retailing | 4.15% | 4.31% | +0.16% |
| 7 | Aarti Drugs Ltd ₹79.96 Cr |
Pharmaceuticals & Biotechnology | 1.10% | 1.17% | +0.07% |
| 8 | Max Healthcare Institute Limited ₹180.51 Cr |
Healthcare Services | 2.59% | 2.63% | +0.04% |
| 9 | FDC Limited ₹45.57 Cr |
Pharmaceuticals & Biotechnology | 0.62% | 0.66% | +0.04% |
| 10 | Cipla Limited ₹396.98 Cr |
Pharmaceuticals & Biotechnology | 5.76% | 5.79% | +0.03% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹259.25 Cr |
Pharmaceuticals & Biotechnology | 4.83% | 3.78% | -1.05% |
| 2 | Sun Pharmaceutical Industries Limited ₹788.06 Cr |
Pharmaceuticals & Biotechnology | 12.31% | 11.49% | -0.82% |
| 3 | Entero Healthcare Solutions Ltd ₹50.92 Cr |
Retailing | 1.23% | 0.74% | -0.49% |
| 4 | Alivus Life Sciences ₹66.27 Cr |
Pharmaceuticals & Biotechnology | 1.21% | 0.97% | -0.24% |
| 5 | Indegene Limited ₹119.17 Cr |
Healthcare Services | 1.92% | 1.74% | -0.18% |
| 6 | Mankind Pharma Limited ₹346.05 Cr |
Pharmaceuticals & Biotechnology | 5.21% | 5.04% | -0.17% |
| 7 | Indoco Remedies Ltd ₹29.35 Cr |
Pharmaceuticals & Biotechnology | 0.58% | 0.43% | -0.15% |
| 8 | AstraZeneca Pharma India Limited ₹126.80 Cr |
Pharmaceuticals & Biotechnology | 1.99% | 1.85% | -0.14% |
| 9 | Dr Agarwals Health Care Limited ₹182.40 Cr |
Healthcare Services | 2.79% | 2.66% | -0.13% |
| 10 | Thyrocare Technologies Limited ₹80.16 Cr |
Healthcare Services | 1.30% | 1.17% | -0.13% |
39 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹788.06 Cr |
Pharmaceuticals & Biotechnology |
11.49%
|
|
| 2 |
₹667.57 Cr |
Pharmaceuticals & Biotechnology |
9.73%
|
|
| 3 |
₹396.98 Cr |
Pharmaceuticals & Biotechnology |
5.79%
|
|
| 4 |
₹365.74 Cr |
Pharmaceuticals & Biotechnology |
5.33%
|
|
| 5 |
₹346.05 Cr |
Pharmaceuticals & Biotechnology |
5.04%
|
|
| 6 |
₹330.36 Cr |
Pharmaceuticals & Biotechnology |
4.81%
|
|
| 7 |
₹295.65 Cr |
Retailing |
4.31%
|
|
| 8 |
₹278.24 Cr |
Pharmaceuticals & Biotechnology |
4.06%
|
|
| 9 |
₹259.25 Cr |
Pharmaceuticals & Biotechnology |
3.78%
|
|
| 10 |
₹240.30 Cr |
Healthcare Services |
3.50%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.